3488 A comparison between the Rolling 6 and 3+3 dose escalation study designs for phase 1 clinical trials

por Minard, Charles Gene, Rau, Rachel, Hilsenbeck, Susan, Weigel, Brenda J., Fox, Elizabeth, Adamson, Peter, Blaney, Susan
Publicado 2019

Associations of Socioeconomic Status, Public vs Private Insurance, and Race/Ethnicity With Metastatic Sarcoma at Diagnosis

por Diessner, Brandon J., Weigel, Brenda J., Murugan, Paari, Zhang, Lin, Poynter, Jenny N., Spector, Logan G.
Publicado 2020

First-dose and steady-state pharmacokinetics of orally administered crizotinib in children with solid tumors: a report on ADVL0912 from the Children’s Oncology Group Phase 1/Pilot...

por Balis, Frank M., Thompson, Patrick A., Mosse, Yael P., Blaney, Susan M., Minard, Charles G., Weigel, Brenda J., Fox, Elizabeth
Publicado 2016

Identification of aggressive Gardner syndrome phenotype associated with a de novo APC variant, c.4666dup

por Kiessling, Patrick, Dowling, Eric, Huang, Yajue, Ho, Mai Lan, Balakrishnan, Karthik, Weigel, Brenda J., Highsmith, W. Edward, Niu, Zhiyv, Schimmenti, Lisa A.
Publicado 2019

Wee1 kinase inhibitor adavosertib with radiation in newly diagnosed diffuse intrinsic pontine glioma: A Children’s Oncology Group phase I consortium study

por Mueller, Sabine, Cooney, Tabitha, Yang, Xiaodong, Pal, Sharmistha, Ermoian, Ralph, Gajjar, Amar, Liu, Xiaowei, Prem, Komal, Minard, Charles G, Reid, Joel M, Nelson, Marvin, Haas-Kogan, Daphne, Fox, Elizabeth, Weigel, Brenda J
Publicado 2022

Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors

por Mascarenhas, Leo, Ogawa, Chitose, Laetsch, Theodore W., Weigel, Brenda J., Bishop, Michael W., Krystal, Julie, Borinstein, Scott C., Slotkin, Emily K., Muscal, Jodi A., Hingorani, Pooja, Levy, Donna E., Mo, Gary, Shahir, Ashwin, Wright, Jennifer, DuBois, Steven G.
Publicado 2021

Metabolic response as assessed by (18)F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rha...

por Harrison, Douglas J., Chi, Yueh‐Yun, Tian, Jing, Hingorani, Pooja, Mascarenhas, Leo, McCowage, Geoffrey B., Weigel, Brenda J., Venkatramani, Rajkumar, Wolden, Suzanne L., Yock, Torunn I., Rodeberg, David A., Hayes‐Jordan, Andrea A., Teot, Lisa A., Spunt, Sheri L., Meyer, William H., Hawkins, Douglas S., Shulkin, Barry L., Parisi, Marguerite T.
Publicado 2020